Analyze Diet
Free radical research2003; 37(4); 461-467; doi: 10.1080/1071576031000068627

Pulmonary bioavailability of ascorbic acid in an ascorbate-synthesising species, the horse.

Abstract: Vitamin C (ascorbic acid) is a non-enzymatic antioxidant important in protecting the lung against oxidative damage and is decreased in lung lining fluid of horses with airway inflammation. To examine possible therapeutic regimens in a species with ascorbate-synthesising capacity, we studied the effects of oral supplementation of two forms of ascorbic acid, (each equivalent to 20 mg ascorbic acid per kg body weight) on the pulmonary and systemic antioxidant status of six healthy ponies in a 3 x 3 Latin square design. Two weeks supplementation with ascorbyl palmitate significantly increased mean plasma ascorbic acid concentrations compared to control (29 +/- 5 and 18 +/- 7 micromol/l, respectively; p < 0.05). Calcium ascorbyl-2-monophosphate, a more stable form of ascorbic acid, also increased mean plasma ascorbic acid concentrations, but not significantly (23 +/- 1 micromol/l; p = 0.07). The concentration of ascorbic acid in bronchoalveolar lavage fluid increased in five out of six ponies following supplementation with either ascorbyl palmitate or calcium ascorbyl-2-monophosphate compared with control (30 +/- 10, 25 +/- 4 and 18 +/- 8 micromol/l, respectively; p < 0.01). Neither supplement altered the concentration of glutathione, uric acid or alpha-tocopherol in plasma or bronchoalveolar lavage fluid. In conclusion, the concentration of lung lining fluid ascorbic acid is increased following ascorbic acid supplementation (20 mg/kg body weight) in an ascorbate-synthesising species.
Publication Date: 2003-05-16 PubMed ID: 12747741DOI: 10.1080/1071576031000068627Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the effects of oral supplementation of two forms of ascorbic acid on the antioxidant status of healthy horses. It concluded that after supplementation, the concentration of ascorbic acid in lung fluid increased, implying a potential strategy for protecting lungs against oxidative damage.

Objective of the Research

  • The main objective of this study was to examine the potential benefits of oral supplementation of ascorbic acid (vitamin C) in horses that naturally synthesise ascorbate. Specifically, it focused on evaluating how the concentration of ascorbic acid in bronchoalveolar lavage fluid, essential for lung health, was impacted.

Research Design and Methodology

  • The researchers used a Latin square design. It is a method of experimentally controlling variation, without using replication.
  • The experiment was performed on six healthy ponies.
  • The two forms of ascorbic acid administered were ascorbyl palmitate and calcium ascorbyl-2-monophosphate. They were each equivalent to 20 mg ascorbic acid per kg body weight.
  • Two-week supplementation was observed, followed by an assessment of both pulmonary and systemic antioxidant status.

Key Findings

  • The study found that supplementation with ascorbyl palmitate significantly increased average plasma ascorbic acid concentrations compared to control.
  • Although calcium ascorbyl-2-monophosphate increased mean plasma ascorbic acid concentrations, the increase was not statistically significant.
  • In five out of six ponies, the concentration of ascorbic acid in bronchoalveolar lavage fluid increased following supplementation with either ascorbyl palmitate or calcium ascorbyl-2-monophosphate compared with control.

Conclusions

  • The study’s findings indicate that oral supplementation of ascorbic acid increases concentrations in lung lining fluid, suggesting potential benefits for lung health in horses.
  • The researchers argue that while further investigation is needed, these results show promise towards potential therapeutic strategies using ascorbic acid supplements for lung health in horses.

Cite This Article

APA
Deaton CM, Marlin DJ, Smith NC, Roberts CA, Harris PA, Kelly FJ, Schroter RC. (2003). Pulmonary bioavailability of ascorbic acid in an ascorbate-synthesising species, the horse. Free Radic Res, 37(4), 461-467. https://doi.org/10.1080/1071576031000068627

Publication

ISSN: 1071-5762
NlmUniqueID: 9423872
Country: England
Language: English
Volume: 37
Issue: 4
Pages: 461-467

Researcher Affiliations

Deaton, Christopher M
  • Centre for Equine Studies, Animal Health Trust, Lanwades Park, Kentford, Suffolk CB8 7UU, UK. chris.deaton@aht.org.uk
Marlin, David J
    Smith, Nicola C
      Roberts, Colin A
        Harris, Pat A
          Kelly, Frank J
            Schroter, Robert C

              MeSH Terms

              • Animals
              • Antioxidants / metabolism
              • Ascorbic Acid / analogs & derivatives
              • Ascorbic Acid / blood
              • Ascorbic Acid / metabolism
              • Ascorbic Acid / pharmacokinetics
              • Ascorbic Acid / pharmacology
              • Bronchoalveolar Lavage Fluid
              • Calcium / pharmacology
              • Chromatography, High Pressure Liquid
              • Glutathione
              • Horses
              • Lung / drug effects
              • Lung / metabolism
              • Time Factors
              • Trachea / drug effects

              Citations

              This article has been cited 0 times.